Login / Signup

Dimerization deficiency of enigmatic retinitis pigmentosa-linked rhodopsin mutants.

Birgit PloierLydia N CaroTakefumi MorizumiKalpana PandeyJillian N PearringMichael A GorenSilvia C FinnemannJohannes GraumannVadim Y ArshavskyJeremy S DittmanOliver P ErnstAnant K Menon
Published in: Nature communications (2016)
Retinitis pigmentosa (RP) is a blinding disease often associated with mutations in rhodopsin, a light-sensing G protein-coupled receptor and phospholipid scramblase. Most RP-associated mutations affect rhodopsin's activity or transport to disc membranes. Intriguingly, some mutations produce apparently normal rhodopsins that nevertheless cause disease. Here we show that three such enigmatic mutations-F45L, V209M and F220C-yield fully functional visual pigments that bind the 11-cis retinal chromophore, activate the G protein transducin, traffic to the light-sensitive photoreceptor compartment and scramble phospholipids. However, tests of scramblase activity show that unlike wild-type rhodopsin that functionally reconstitutes into liposomes as dimers or multimers, F45L, V209M and F220C rhodopsins behave as monomers. This result was confirmed in pull-down experiments. Our data suggest that the photoreceptor pathology associated with expression of these enigmatic RP-associated pigments arises from their unexpected inability to dimerize via transmembrane helices 1 and 5.
Keyphrases
  • wild type
  • poor prognosis
  • drug delivery
  • fatty acid
  • air pollution
  • optical coherence tomography
  • diabetic retinopathy
  • electronic health record
  • machine learning
  • binding protein